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SHORT REPORT
First case of chronic wasting disease 
in Europe in a Norwegian free-ranging reindeer
Sylvie L. Benestad1*, Gordon Mitchell2, Marion Simmons3, Bjørnar Ytrehus4 and Turid Vikøren1
Abstract 
Chronic wasting disease (CWD) is a fatal contagious prion disease in cervids that is enzootic in some areas in North 
America. The disease has been found in deer, elk and moose in the USA and Canada, and in South Korea following the 
importation of infected animals. Here we report the first case of CWD in Europe, in a Norwegian free-ranging reindeer 
in Southern Norway. The origin of the disease is unknown. Until now a low number of cervids, and among them a few 
reindeer, have been tested for CWD in Norway. Therefore the prevalence of CWD is unknown.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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Introduction, methods, and results
Chronic wasting disease (CWD) is a fatal neurodegen-
erative disorder that affects cervids. CWD belongs to a 
group of prion diseases, which include scrapie in small 
ruminants, bovine spongiform encephalopathy (BSE) in 
cattle and Creutzfeldt-Jakob disease in humans.
The development of the disease is associated with the 
misfolding of a host-encoded prion protein, (PrPC) into 
resistant conformers (PrPres also called PrPCWD in cer-
vids) which accumulate in the central nervous system, 
and ultimately results in death of the animal.
CWD has been diagnosed in captive and free-ranging 
cervids in 24 American states and two Canadian prov-
inces [1].
It affects different species in the family Cervidae, mule 
deer (Odocoileus hemionus), white-tailed deer (Odoc-
oileus virginianus), elk (Cervus canadensis) and moose 
(Alces alces) [2–4]. In addition, CWD has been diagnosed 
in red deer (Cervus elaphus) and sika deer (Cervus nip-
pon) in South Korea as the result of importing CWD-
infected elk from North America [5].
The clinical signs of CWD have mainly been observed 
in captive animals and are subtle and vary from case 
to case [6]. The first clinical signs are nonspecific and 
include variable behavioral changes such as listless-
ness, isolation from the herd, lowering of head and ears, 
repetitive walking and hyperexcitability, followed by 
weight loss. Other signs are polydipsia/polyuria, hyper-
salivation, grinding of the teeth, frequent regurgitation 
and difficulty swallowing. Secondary aspiration pneumo-
nia may occur and stress can trigger the appearance of 
clinical signs and may lead to unexpected mortality. Dis-
eased animals do not lose their appetite and often their 
rumens are filled with food, sometime with an excessive 
amount of water and sometimes dry. The duration of 
clinical disease varies among individuals, ranging from 
weeks to months.
Experimentally, CWD is transmissible to a range of 
cervids [7, 8]. In addition, a large spectrum of mammals 
are shown to be susceptible to CWD by intracerebral 
inoculation, like sheep, goats, cattle, cats, some rodents 
species (reviewed in [9]) and a series of transgenic mice 
carrying the PrP gene of different species [10]. The exper-
imental transmission of CWD to non-cervid species by 
oral challenge is far less efficient, indicating a high spe-
cies barrier under natural conditions. Interestingly, rein-
deer (Rangifer tarandus tarandus) have been shown to be 
susceptible to experimental oral transmission [11] while 
the North American subspecies of reindeer (R. tarandus) 
known as caribou, have not been diagnosed with CWD.
Four cervid species are prevalent in free-ranging popu-
lations in Norway: moose (Alces alces), red deer, roe deer 
(Capreolus capreolus), and reindeer. Norway harbors 
what is considered as the last remnants of wild tundra 
reindeer (Rangifer tarandus tarandus) in Europe, with 
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approximately 25 000 animals in the winter population. 
The species is found in fragmented sub-populations in the 
remote alpine regions of Southern Norway. Most of the 
sub-populations make short-range seasonal migrations 
between different pasture areas and congregate in large 
herds in periods of the year. Here we report the first case 
of CWD in Europe in a free-ranging Norwegian reindeer.
A herd of approximately 400 free-ranging reindeer 
from the Nordfjella (Southern Norway) sub-population 
was approached by helicopter on March 2016. This was 
done in an attempt to chemically immobilize an individ-
ual animal to place a radio-collar, as part of a larger study 
addressing the spatiotemporal interactions between 
reindeer and humans. The CWD reindeer described in 
this report was found as the research crew searched for 
a missing dart in an area not far from where the herd 
first was approached. Judging by the tracks in the snow, 
this individual had split off from the main herd and run 
downhill, at first leaving a normal track, but afterwards 
leaving tracks suggestive of dragging one of its right 
limbs. The female reindeer was found recumbent, but 
did still have eye reflexes and could move its limbs. It had 
small amounts of white froth on its lips, a raised body 
temperature of 41.9 °C and it died shortly after. Because 
the case reported here involved an animal who died of 
natural causes, ethics approval is not required.
Based on dental eruption and wear, the reindeer was an 
adult over 2.5 years old, probably in the range of 3–4 years. 
Necropsy revealed that the female reindeer was not preg-
nant and was in below average body condition, weighing 
43  kg and having only small amounts of body fat. It had 
small areas of hair loss on the chest, the elbows and the 
thighs. The main gross findings were multiple hemorrhages 
and ruptures in the skeletal muscles most prominent in the 
hind quarters, general congestion, and lung edema with 
areas of consolidation in the right cranial lung lobe. Tis-
sue samples of brain, heart, lung, tracheobronchial lymph 
nodes, liver, kidney and skeletal musculature were fixed in 
10% buffered formalin, routinely processed and embedded 
in paraffin before cutting sections (5 µm) that were stained 
with haematoxylin-eosin (HE) for histological examination.
Histology revealed acute degeneration of skeletal 
musculature and acute multifocal catarrhal broncho-
pneumonia with small amounts of foreign material in 
the inflamed lung tissue. In the brain, histopathological 
examination of the obex revealed vacuolation, especially 
in the dorsal motor nucleus of the vagus nerve (DMNV) 
(Figure  1A), in the neuropil and in neurons. However, 
the brain tissue showed a mild to moderate degree of 
autolysis which precluded an accurate description of the 
spongiform degeneration.
The medulla oblongata of this animal was analyzed 
by using a commercially available Enzyme-Linked 
Immunosorbent Assay test for detection of abnormal prion 
protein (PrPres) (TeSeE ELISA Bio-Rad) according to the 
manufacturers’ instructions. After an initial positive result, 
six other samples taken from different areas of the medulla 
and one from the cerebral cortex were also analyzed and 
found to be strongly positive (OD values above 2.9).
The presence of PrPres was further demonstrated by a 
commercially available Western blot test (TeSeE Western 
blot, Bio-Rad) using the monoclonal antibodies SHa31 (AbI 
kit reagent) together with an additional monoclonal anti-
body, P4 at a dilution of 1:1000. The medulla sample of the 
reindeer displayed a proteinase K (PK)-resistant 3-bands 
pattern between 17 and 29 kDa, identical to patterns from 
an American elk CWD control (kindly provided by Terry 
Spraker, CSU Vet Diagnostics Lab, CO, USA) (Figure 2).
The distribution of PrPCWD was visualized in the brain 
tissues and in two tracheobronchial lymph nodes by 
immunohistochemical labelling using the antibodies 
F89/160.1.5 and 2G11 which bind to residues 142–145 
and 149–161 of ovine PrP respectively. Briefly, tissue 
sections on poly-l-lysine glass slides were deparaffin-
ised, rehydrated, treated in formic acid 98% for 30  min 
and boiled by hydrated autoclaving at 121  °C in 0.01 M 
citric acid, pH 6.1 for 30  min. A commercially avail-
able kit (EnVisionTM  +  System HRP (AEC) DAKO, 
Glostrup, Denmark) was applied with a mixture of mAb 
F89/160.1.5 and 2G11 at a dilution of 1:700 and 1:200 
respectively for 30 min at 37 °C.
The obex region showed a strong particulate coalesc-
ing, perineuronal labelling of PrPCWD especially in the 
DMNV. Less severely affected nuclei included the spinal 
tract of the trigeminal nerve, hypoglossal nucleus and the 
area postrema, and some labelling was seen in the cune-
ate nucleus, medial lemniscus and the olivary nuclei. The 
PrPCWD labelling in the cerebellum was less prominent, 
with patchy labelling in some areas, often heavier in the 
granular layer, and moderate in the form of stellate label-
ling reminiscent of astroglial processes in the molecular 
layer. The remaining regions of the brain displayed PrP-
CWD labelling (coarse, patchy, stellar, plaque-like, perivas-
cular, linear or intraneuronal) as illustrated in Figure  3. 
Labelling was more prominent in the ventral regions of 
the brain. Marked PrPCWD immunolabelling was present 
in the lymphoid follicles of the tracheobronchial lymph 
nodes.
For labelling of astrocytes, the glial fibrillary acidic 
protein (GFAP), the EnVisionTM +  System HRP (AEC) 
DAKO, Glostrup, Denmark kit protocol was applied 
using polyclonal anti-GFAP antibody (DAKO Z 334 
Glostrup, Denmark) at a dilution of 1:2000 for 30  min. 
The obex showed marked immunolabelling (Figure 1B).
Genomic DNA was extracted from frozen brain and 
the prion protein gene (PRNP) open reading frame was 
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amplified and sequenced (Applied Biosystems 3500×L 
genetic analyzer with Big Dye Terminator chemistry). 
The PRNP sequence of this reindeer was identical to 
that of the two reindeer that were previously found to 
be susceptible to CWD by experimental oral infection 
(homozygous V (valine), G (glycine), S (serine) and V at 
codons 2, 129, 138 and 169) [11].
Discussion
This case of CWD in a free-ranging Norwegian reindeer 
is the first report of naturally occurring CWD in Europe. 
The disease was detected through the routine CWD test-
ing of cervids older than 18 months that are necropsied 
at the Norwegian Veterinary Institute. Other pathologi-
cal findings were consistent with acute exertional (cap-
ture) myopathy and small areas of aspiration pneumonia, 
both probably secondary to CWD. Exertional myopathy 
is associated with physiological imbalances following 
extreme exertion and stress, and it is reported that deer 
with subclinical or early clinical CWD are susceptible 
to sudden death after stressful situations [6]. Aspiration 
pneumonia is well documented in animals suffering from 
CWD and difficulty in swallowing and a flaccid esopha-
gus with reduced muscular tone have been suggested as 
possible explanations [4]. This reindeer was not emaci-
ated, but she was in poor body condition as compared to 
a healthy non-pregnant female reindeer in late winter. In 
conclusion, based on the case history and the relatively 
widespread distribution of PrPCWD in the brain, there 
is reason to conclude that the animal had a spongiform 
encephalopathy compatible with CWD at an early clini-
cal stage.
The presence of two different strains has been demon-
strated in North American CWD isolates when passaged 
into ferrets [12], Syrian hamsters [13] and transgenic 
mice with cervid PrP [14]. The strains are designated dif-
ferently (CWD-WI and CWD-CSU, Sgha CWDmd-f and 
Sgha CWDmd-s, or CWD1 and CWD2) in ferrets, Syrian 
hamsters and mice, respectively. Each “pair” comprises a 
strain transmitting disease after a short incubation time 
and providing a widespread distribution of PrPres in the 
CNS, and a second strain with a longer incubation time 
and more limited deposition of PrPres. Notably, there are 
no differences in the biochemical glycoprofile between 
the two strains, which makes it impossible to distinguish 
them without bioassays [14]. The Norwegian CWD rein-
deer isolate had a similar glycoprofile to the American elk 
Figure 1 Histology of the obex. A HE staining showing vacuoles in the neurons and neuropil ×600. B Glial fibrillary acidic protein (GFAP) immu-
nolabelling showing strong proliferation of reactive astrocytes (gliosis) in the obex area ×400.
Figure 2 Western blot detection of PrPres with TeSeE Western 
blot kit (Bio-Rad), using SHa31 and P4 mAb. The Norwegian 
reindeer sample (Nor CWD) showed a typical 3-band pattern similar 
to the American elk CWD sample (Am elk CWD). No signal was seen 
in the negative sheep brain sample (Neg).
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CWD sample (Figure 2) and Canadian CWD isolates used 
as controls for the Western blot analysis (Additional file 1), 
including reindeer orally inoculated with CWD material 
[11]. The immunohistochemical distribution of PrPCWD in 
the obex, the cerebellum and the lymph nodes by IHC was 
also comparable to those found in Canadian reindeer suc-
cessfully orally challenged with CWD. Transmission stud-
ies have now been initiated on a panel of transgenic mice 
to characterize the Norwegian reindeer isolate.
A major question concerns the origin of CWD in 
Norway. Importation of CWD infected deer could be 
the source of infection, as was the case in South Korea. 
However, Norway has strict legislation and enforcement 
regarding the importation of live animals and importa-
tion of cervids is not allowed. The only exceptions are a 
few moose that have been imported to zoos from Swe-
den. All red deer (Cervus elaphus) kept in farms originate 
from wild Norwegian populations. We find it unlikely 
Figure 3 IHC labelling of PrPCWD using F89/160.1.5 and 2G11 mAb. A Obex, intense coarse particulate labelling in the DMNV ×200. B 
Cerebellum, patchy labelling in the granular layer and stellate in the molecular layer ×200. C Ventral midbrain, scattered granules or accumulations 
of PrPCWD that appear as plaques ×400. D Ventral midbrain, neuronal and axonal labelling ×400. E Ventral midbrain, linear type labelling ×100. F 
Dorsal midbrain, sparse immunolabelling, plaque-like accumulation of PrPCWD ×100.
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that this CWD case is due to imported infected cervids 
unless illegal imports from North  America to Norway 
have taken place. It is however noteworthy that Finland’s 
white tailed deer population, estimated at 60 000 animals, 
originated from one import from North America in 1934 
of four does and one buck. Due to the CWD situation in 
North America, Finland targeted TSE testing especially 
to the white tailed deer in the period between 2003 and 
2015, and a total of 643 white tailed deer have been tested 
and found negative for CWD (Sirkka-Liisa Korpenfelt, 
EVIRA, Finland, personal communication).
Another possibility of contamination is through hunt-
ing urine baits imported from North America, but for the 
time being, no information about the use of these baits in 
Norway is available.
It has been speculated that the origin of CWD in North 
American cervids may be associated with classical scra-
pie because some scrapie infected sheep had been penned 
together with deer at a research center between 1968 and 
1971 [4, 15, 16]. To support this hypothesis, Tamgüney 
[17] reported the successful transmission of one classical 
scrapie isolate into transgenic mice carrying the elk prion 
protein gene [Tg(ElkPrP) mice], but it is noteworthy that 
the agent signature (as defined by lesion profile) in these 
mice was different from that in mice inoculated with 
CWD, suggesting that the scrapie and CWD agent were 
distinct strains. Norway has had a scrapie surveillance 
program in place since 1997 with a total of 264 000 small 
ruminants analyzed. Few cases of classical scrapie have 
been diagnosed in Norway and the last case was identified 
in 2009. There are no reports of classical scrapie within 
the range of the Nordfjella reindeer sub-population, but as 
sheep traditionally are transported over long distances to 
graze in mountain pastures, it cannot be formally excluded 
that reindeer in this or a nearby subpopulation could have 
been exposed to sheep with classical scrapie at some point 
of time.
In contrast to classical scrapie is Nor98/atypical scrapie 
diagnosed in sheep in Norway. Between five and 13 cases 
have been identified each year the past 10 years, and they 
are found over the whole country, including where the 
CWD reindeer was discovered. Whether Nor98/atypical 
scrapie could be the source of CWD in Norway cannot 
be excluded, despite the fact that, as it could be expected 
in case of direct transmission, the distinctive molecular 
signature of Nor98/atypical scrapie, a multiband WB pat-
tern [18] was not observed in the present reindeer.
A plausible alternative to the occurrence of CWD in 
Europe could be that a cervid developed a genetic or 
spontaneous TSE which subsequently spread horizon-
tally to other cervids. As cervids may eat or gnaw on 
remnants of carcasses, we may speculate that there could 
have been an incident more or less analogous to the Kuru 
epidemic on Papua New Guinea, which is suggested to 
have started with ritual cannibalism of an individual with 
sporadic Creutzfeldt-Jakob Disease [19].
Currently we have no information about the distribu-
tion and prevalence of CWD in the Norwegian cervid 
population. Whether CWD is contagious among rein-
deer is also an open question, but should be expected. 
The social behavior of reindeer living close together in 
herds and grazing on the ground may increase the likeli-
hood for CWD transmission. As opposed to most of the 
prion diseases, infectivity in cervids is demonstrated in 
many peripheral tissues, such as muscles [20], elk ant-
ler velvet [21], endocrine glands [22] and in excreta like 
urine, saliva, blood and feces [23–26]. In the present rein-
deer, PrPCWD was detected by IHC in the tracheobron-
chial lymph node. This vast distribution of infectivity in 
the host, together with a high stability of prions in the 
environment [27–29] can explain why CWD is known as 
the most contagious prion disease, with a prevalence of 
up to 30% in free-ranging herds or 90% in captive herds 
[6, 30] and we should be prepared for detecting addi-
tional CWD cases in the Norwegian cervid population.
Norway has a particular responsibility to manage and 
protect the last remnant of the wild tundra reindeer in 
Europe, and the detection of CWD in one of these sub-
populations is of great concern. Efforts are being made 
to reduce the migration of reindeer from Nordfjella 
to neighboring sub-populations and known migration 
paths are being monitored. Measures such as intensified 
nationwide CWD surveillance are being planned by the 
Norwegian Food Safety Authority and the Norwegian 
Environment Agency.
Surveillance for CWD in Europe has been limited. In 
Norway, approximately 2200 cervids have been tested 
from 2004 to 2015, of which only ten were free-rang-
ing reindeer, but none were from the Nordfjella area. 
The small number of wild reindeer tested reflects that 
the chances of a sick animal in such remote areas being 
observed, reported and submitted for testing are small. 
The European Food Safety Authority (EFSA) stated that 
the occurrence of CWD could not be excluded in cervids 
in Europe, “especially in remote and presently unsampled 
areas” (EFSA journal 2010). Because of the limitation 
of the surveillance program in cervids, it is not possible 
to exclude that CWD has been present in Norway or 
Europe for decades without being detected until now. 
This assumption is strengthened by the discovery, at the 
time of writing of this paper, of two additional CWD 
cases in moose in Norway, originating from a region situ-
ated about 300  km from the Nordfjella area where the 
CWD infected reindeer was found. The prevalence, epi-
demiology and implications of CWD in Norwegian and 
European cervids remain to be determined.
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CWD is enzootic in multiple regions in North America 
and unfortunately the disease is spreading. To our knowl-
edge, this is the first case report of CWD in Europe and 
the first case of the disease naturally occurring in rein-
deer worldwide. The origin, prevalence, and incidence 
of CWD in Norway are currently not known, but being 
investigated.
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Additional file 1. Western blot detection of PrPres with TeSeE West-
ern blot kit (Bio-Rad), using SHa31 mAb, upper figure, or P4 mAb, 
lower figure. A typical di-, mono- and unglycosylated protein banding 
pattern characteristic of CWD in cervids, was observed in the homoge-
nate prepared from the Norwegian reindeer (16TSE96). Comparable 
molecular weight and glycoform ratios were found in the North American 
positive controls from different cervid species (white-tailed deer, elk, red 
deer), including experimentally infected reindeer (reindeer #s 12, 47 and 
112) [11].
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